Healthcare
Biotech player, Imugene Soars 27% on ASX; Glance Through Key Developments
November 11, 2019 10:39 PM AEDT| By Team Kalkine MediaClinical-stage biotech player Imugene Limited (ASX: IMU) soared ~27 per cent on the ASX today, settling the day?s trade at $0.033 on 11th November 2019. The stock has delivered a substantial return of ~53 per cent in the last six months, driven by si...
Vibrant Market Opportunity Awaits Cortical’s Industry Disruptive Technology
November 11, 2019 03:47 PM AEDT| By Team Kalkine MediaMedical device company Cortical Dynamics Limited which is headquartered in Australia remains focused on the development of Brain Anaesthesia Response Monitor (BARM) based on an industry disruptive technology. Cortical’s breakthrough system addr...
Shedding light on the Recent Fuss about RAS, Prescient released AusBiotech Presentation
November 11, 2019 02:42 PM AEDT| By Team Kalkine MediaWith a focus on addressing mutations causing cancer, Prescient Therapeutics Limited (ASX:?PTX) develops personalised medicines as potential novel cancer remedies targeting an array of debilitating cancers with significant unmet need. ?Prescient has a...
6 Ideas to Help You Invest Like A Pro in Health Care Stocks
November 08, 2019 04:56 PM AEDT| By Team Kalkine MediaAustralia?s health care industry is one of the fastest growing industries in the country that is making substantial progress driven by new technological advancements. The country?s government is injecting billions of dollars into modernising and deve...
BPH Energy’s Investee Advent Energy Makes Considerable Progress with PEP 11 Permit
November 07, 2019 09:51 PM AEDT| By Team Kalkine MediaDiversified player, BPH Energy Limited (ASX:BPH) holds investments in a range of sectors, including resources (Advent Energy Ltd), biotechnology (Cortical Dynamics Limited and Molecular Discovery Systems) and medical cannabis (Patagonia Genetics Pty...
Importance of Drug Development for Biotech Companies – NEU, TLX, PXS, RGS, BIT
November 06, 2019 05:27 PM AEDT| By Team Kalkine MediaDrug Development Process The drug development process starts from drug discovery and ends at the launch of the new pharmaceutical product in the market. The process includes drug discovery and development, preclinical trials, clinical trials, regula...
Market share for Health Care Giant CSL - The race in the Immunoglobulin space
November 06, 2019 04:16 PM AEDT| By Team Kalkine MediaPharmaceutical giant with one of the largest and fastest-growing protein-based biotechnology business, CSL Limited (ASX: CSL) continued to be the market darling throughout the year with its share price reaching its all-time high of $262.0 on 4 Novemb...
Imugene Limited Receives $4.13 Million R&D Tax Refund from Australian Government
November 06, 2019 03:35 PM AEDT| By Team Kalkine MediaAustralian immuno-oncology company, Imugene Limited (ASX: IMU) is developing a pipeline of mimotope-based B-cell immunotherapies against oncology targets that could replace or be used in combination with monoclonal antibodies. The company intends to...
Prescient’s September 2019 Quarterly Update Unveils Encouraging Developments
November 06, 2019 03:29 PM AEDT| By Team Kalkine MediaPrescient Therapeutics Limited (ASX:?PTX) is a clinical-stage oncology company focused on developing personalised medicines as potential novel targeted cancer therapies for a range of challenging cancers with significant unmet need. Prescient?s appro...
What’s the Buzz around Health Care Stock Pro Medicus?
November 05, 2019 04:49 PM AEDT| By Team Kalkine MediaWhat?s the Buzz around Health Care Stock Pro Medicus? Incorporated in 1983 and listed on ASX in 2000, Pro Medicus Limited (ASX: PME) is a group within the health care domain that serves imaging centres, hospitals and other health care groups globall...
Are There Any Exciting ASX Opportunities in Health Care Industry - BNO, PME, EBO, ANN, NAN, HLS
November 05, 2019 02:10 PM AEDT| By Team Kalkine MediaHealth care industry is one of the world?s fastest-growing industries, providing services to treat patients with preventive, curative and palliative care. The industry includes pharmaceutical & biotech companies, medical device producers & di...
A Flick Through BPH Energy’s Annual Report 2019
November 04, 2019 07:45 PM AEDT| By Team Kalkine MediaAustralia-based diversified player, BPH Energy Limited (ASX: BPH) invests in various sectors, including medical cannabis, biotech and oil and gas, and holds significant interests in Advent Energy Ltd, Molecular Discovery Systems, Patagonia Genetics P...
Is Investing In ASX Healthcare Stocks A Good Idea?
November 02, 2019 08:45 AM AEDT| By Team Kalkine MediaAustralian health care system is developing rapidly and is one of the best healthcare systems across the globe. It comprises of pharmaceutical manufacturing companies, biotech companies, medical device manufacturers & distributors, laboratories a...
Is Starpharma The New Star in Health Care Domain?
November 01, 2019 08:25 PM AEDT| By Team Kalkine MediaHealth care sector in Australia is growing tremendously and players are investing a considerable amount in their research and development for providing new treatment for rare diseases and finding therapies for unmet medical needs. Clinical studies ad...
Health Care Segment Is All About Vouching For Opthea and PolyNovo - Are These The Top Ones?
November 01, 2019 07:19 PM AEDT| By Team Kalkine MediaIn recent years, Australia?s health care industry has remarkably grown in terms of size and reputation for its world-leading technology, advanced R&D, innovation, leading scientists and health care professionals. Australia is one of the best loca...
Capital Raising in Health Space-Diagnostic Company Genetic Signature Under Focus
November 01, 2019 04:03 PM AEDT| By Team Kalkine MediaHealth care sector During the past several years, the Australian Health Care Sector had seen rapid development, and as a result it stands out as one of the best health care systems in the world, delivering safe, effective and affordable health solut...
Noxopharm takes another leap forward with Veyonda® Confirming Durable Anti-Cancer Effect in DARRT-1 Study
October 29, 2019 03:11 PM AEDT| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) has recently provided an update related to the research progress on its key drug candidate Veyonda® which is presently undergoing clinical trials in late-stage, progressive and metastatic, castration-resistant pr...
Lens through Imugene’s September 2019 Quarterly 4C Report
October 29, 2019 02:31 PM AEDT| By Team Kalkine MediaBiotechnology firm headquartered in Australia, Imugene Limited (ASX: IMU) is a clinical stage immuno-oncology player that develops novel immunotherapies to treat and eradicate cancerous tumours. The company?s unique platform technologies hold the pot...
Look at Pharmacy Businesses and 3 Related ASX Healthcare Stocks – MSB, SPL, API
October 28, 2019 03:58 PM AEDT| By Team Kalkine MediaPharmacy businesses are increasingly becoming a focal point for investments by businesses and market players, given the huge market opportunity that lies ahead. As per the US National Institute of Health, the development of a new medicine is a long,...
What’s New With Health Care Players - AGH, BOT, NEU, CYP, ALC
October 26, 2019 09:30 AM AEDT| By Team Kalkine MediaHealth care system of Australia is considered as one of the best, globally, as it delivers safe and affordable health care solutions and services to the citizens. Health care sector in Australia comprises of medical service, medical insurance and med...
Advertise your brand on Kalkine Media